# Evaluation of Biocompatibility and Performances of 4 Dialyzers in Different Mode Treatments

> **NCT03262272** · NA · COMPLETED · sponsor: **Hemotech** · enrollment: 32 (actual)

## Conditions studied

- End Stage Renal Disease
- Inflammation

## Interventions

- **DEVICE:** VIE A Hemodialyzer
- **DEVICE:** Rexsys 27H hemodialyzer
- **DEVICE:** Leoceed 21HX hemodialyzer
- **DEVICE:** Polypure 22S+ hemodialyzer

## Key facts

- **NCT ID:** NCT03262272
- **Lead sponsor:** Hemotech
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-21
- **Primary completion:** 2018-07-31
- **Final completion:** 2018-10-31
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2019-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03262272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03262272, "Evaluation of Biocompatibility and Performances of 4 Dialyzers in Different Mode Treatments". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03262272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*